Literature DB >> 25686915

The influence of low-level laser therapy with alendronate irrigation on healing of bone defects in rats.

Utkan Kamil Akyol1, Sare Sipal, Elif Demirci, Metin Gungormus.   

Abstract

The aim of this study was to investigate the effects of alendronate (Aln) irrigation with low-level laser therapy (LLLT) on the healing of bone defects in rats. Sixty Wistar rats weighing 250 to 300 g were randomly divided into three groups of 20 animals each: (1) control group, (2) Aln group, and (3) Aln with LLLT group. The distal epiphysis of all rats was perforated with a surgical bone drill. Twenty rats served as control. The bone defects of 40 rats received local alendronate sodium trihydrate irrigation (1 mg/ml) at the time of surgery. LLLT was applied to the bone defects of 20 rats immediately after Aln irrigation, and repeated on days 2, 4, 6, and 8 with a total dose of 10 J/cm(2) (2 J/cm(2) × 5). Continuous wave of GaAlAs laser (808 nm) was used with a power density of 0.1 W/cm(2). Laser energy was applied for 20 s (0.1 W × 20 s/1 cm(2)) per session. Control group, Aln group, and Aln with LLLT group rats were sacrificed at days 10 and 20 to compare the bone healing of each group histologically. There were significant differences between the three groups regarding union, substantia spongiosa, cortex formation, and in sum of histologic scores on days 10 and 20 (P < 0.0001). Our findings demonstrated that Aln has a more positive effect with LLLT on bone healing in rats. It was concluded that combining LLLT (808 nm laser at 10 J/cm(2)) with Aln irrigation has a beneficial effect in bone repair. It was demonstrated experimentally that Aln irrigation during the surgery had a significant effect to enhance bone formation, and LLLT significantly potentiated the osseous healing effects of Aln on bone defects. This administration method is able to minimize the dose of Aln in order to avoid both systemic and local adverse effects as well as the local injection times during the bone healing process.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25686915     DOI: 10.1007/s10103-015-1720-y

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  26 in total

1.  Soaking morselized allograft in bisphosphonate can impair implant fixation.

Authors:  Thomas Jakobsen; Jørgen Baas; Joan E Bechtold; Brian Elmengaard; Kjeld Søballe
Journal:  Clin Orthop Relat Res       Date:  2007-10       Impact factor: 4.176

2.  Experimental comparison of the effects of locally administered zoledronic acid and alendronate on the rate of mandibular distraction osteogenesis in dogs.

Authors:  Abdel Aziz Baiomy; Mohamed A Nassan; Elsaeed M Abdellatif; Ashraf Abdel Fattah; Ahmed A H El-Fekey; Abdel Bassit M Abdel Aal
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12-20

3.  Effects of LLLT in combination with bisphosphonate on bone healing in critical size defects: a histological and histometric study in rat calvaria.

Authors:  Valdir Gouveia Garcia; Juliana Mendonça da Conceição; Leandro Araújo Fernandes; Juliano Milanezi de Almeida; Maria José Hitomi Nagata; Alvaro Francisco Bosco; Leticia Helena Theodoro
Journal:  Lasers Med Sci       Date:  2012-02-28       Impact factor: 3.161

4.  Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.

Authors:  Chih-Tai Leu; Eva Luegmayr; Leonard P Freedman; Gideon A Rodan; Alfred A Reszka
Journal:  Bone       Date:  2005-09-26       Impact factor: 4.398

5.  Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.

Authors:  K Still; R J Phipps; A Scutt
Journal:  Calcif Tissue Int       Date:  2002-12-04       Impact factor: 4.333

6.  Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy.

Authors:  R Lindsay; N B Watts; J L Lange; P D Delmas; S L Silverman
Journal:  Osteoporos Int       Date:  2013-04-24       Impact factor: 4.507

7.  A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients.

Authors:  Toru Yoshioka; Nobukazu Okimoto; Ken Okamoto; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2012-10-19       Impact factor: 2.626

Review 8.  Bisphosphonates: a review of their pharmacokinetic properties.

Authors:  J H Lin
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

9.  Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats.

Authors:  Masafumi Kashii; Jun Hashimoto; Takayoshi Nakano; Yukichi Umakoshi; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

10.  Enhancement of bone formation in rat calvarial bone defects using low-level laser therapy.

Authors:  Maawan Khadra; Nesrin Kasem; Hans R Haanaes; Jan E Ellingsen; Ståle P Lyngstadaas
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2004-06
View more
  1 in total

1.  Low-level laser therapy (780 nm) combined with collagen sponge scaffold promotes repair of rat cranial critical-size defects and increases TGF-β, FGF-2, OPG/RANK and osteocalcin expression.

Authors:  Lana Sarita de Souza de Oliveira; Aurigena Antunes de Araújo; Raimundo Fernandes de Araújo Júnior; Carlos Augusto Galvão Barboza; Boniek Castillo Dutra Borges; José Sandro Pereira da Silva
Journal:  Int J Exp Pathol       Date:  2017-05-29       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.